{"candidates":[{"best_route_status":"INCOMPLETE","candidate_id":"E14Q4B2822A99BAEC01","confidence":0.94,"reason":"Repeated infusion and rescue dosing are described, but no persistent reduced responsiveness is reported.","route_assessments":[{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC01R01L01","evidence":"The service uses a maintenance infusion and sometimes gives closely spaced rescue doses.","status":"SATISFIED"},{"condition_id":"E14Q4B2822A99BAEC01R01L02","evidence":"Early weak relief followed by a sharp combined effect does not establish persistent reduced responsiveness.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC01R01","route_status":"INCOMPLETE"}]},{"best_route_status":"CONTRADICTED","candidate_id":"E14Q4B2822A99BAEC02","confidence":0.95,"reason":"The described activity includes an ongoing maintenance infusion rather than sparse bursts separated by quiescence.","route_assessments":[{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC02R01L01","evidence":"An unchanged maintenance infusion runs over the shift; rescue doses are sometimes closely spaced.","status":"CONTRADICTED"},{"condition_id":"E14Q4B2822A99BAEC02R01L02","evidence":"No ordinary steady-state handling capacity or burst exceedance is described.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC02R01L03","evidence":"No bounded temporary-absorption property is stated.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC02R01L04","evidence":"No prioritization among burst arrivals is described.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC02R01L05","evidence":"No recovery, backlog, fatigue, or maintenance debt from burst handling is reported.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC02R01","route_status":"CONTRADICTED"}]},{"best_route_status":"INCOMPLETE","candidate_id":"E14Q4B2822A99BAEC03","confidence":0.97,"reason":"The scenario describes time-varying drug effects, not recurrent stakeholder-level causal-loop problems.","route_assessments":[{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC03R01L01","evidence":"No repeated reasonable fixes or recurrence after fixes is reported.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC03R01L02","evidence":"No stakeholder symptom accounts connected by system loops are described.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC03R01L03","evidence":"No local optimization worsening the whole system is described.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC03R01L04","evidence":"No short-term relief followed by relapse or renewed constraint is reported.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC03R01L05","evidence":"No disagreement among actors about causes is stated.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC03R01L06","evidence":"No comparison to recurring archetypes is provided.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC03R01","route_status":"INCOMPLETE"}]},{"best_route_status":"INCOMPLETE","candidate_id":"E14Q4B2822A99BAEC04","confidence":0.97,"reason":"No symptom-focused intervention history, system map, or leverage-point evidence is given.","route_assessments":[{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC04R01L01","evidence":"No repeated symptom-focused interventions or displacement is described.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC04R01L02","evidence":"No candidate intervention points are compared.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC04R01L03","evidence":"No compact rule or bottleneck shaping many downstream actions is identified.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC04R01L04","evidence":"No system or stakeholder map is described.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC04R01L05","evidence":"No existing symptom-level intervention pattern is stated.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC04R01","route_status":"INCOMPLETE"}]},{"best_route_status":"INCOMPLETE","candidate_id":"E14Q4B2822A99BAEC05","confidence":0.94,"reason":"The scenario shows a safety-benefit range but does not establish active narrow-score optimization or diminishing returns.","route_assessments":[{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC05R01L01","evidence":"Pain scores and toxicity are measured, but active optimization of a narrow target or score is not stated.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC05R01L02","evidence":"No diminishing marginal improvement from additional optimization is reported.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC05R01L03","evidence":"Higher rates increase toxicity, but continuing improvement in the optimized target is not established.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC05R01","route_status":"INCOMPLETE"}]},{"best_route_status":"INCOMPLETE","candidate_id":"E14Q4B2822A99BAEC06","confidence":0.96,"reason":"The scenario describes delayed clinical response, not unreliable operation completion and retries.","route_assessments":[{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC06R01L01","evidence":"No caller or inability to observe operation completion is described.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC06R01L02","evidence":"Duplicate requests or submissions are not reported.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC06R01L03","evidence":"Drug delivery has clinical effects, but no discrete operation with specified downstream side effects is described.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC06R01L04","evidence":"Retries are not mentioned.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC06R01","route_status":"INCOMPLETE"}]},{"best_route_status":"INCOMPLETE","candidate_id":"E14Q4B2822A99BAEC07","confidence":0.97,"reason":"No adaptation-through-challenge or overprotection pattern is established.","route_assessments":[{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC07R01L01","evidence":"No immediate performance being mistaken for durable capacity is described.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC07R01L02","evidence":"No adaptive repair, consolidation, or structural change is reported.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC07R01L03","evidence":"The safety range concerns drug input and toxicity, not adaptation versus injury from challenge.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC07R01L04","evidence":"No repeated challenge progression and recovery requirement is stated.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC07R01L05","evidence":"No overprotected, under-practiced, or brittle environment is described.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC07R01","route_status":"INCOMPLETE"}]},{"best_route_status":"INCOMPLETE","candidate_id":"E14Q4B2822A99BAEC08","confidence":0.98,"reason":"No stabilized low-malleability target or failed ordinary training/compensation is described.","route_assessments":[{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC08R01L01","evidence":"The scenario concerns inferred drug concentrations and response dynamics, not target malleability.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC08R01L02","evidence":"No ordinary training or compensation attempt, insufficiency, or risk-benefit comparison is stated.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC08R01","route_status":"INCOMPLETE"}]},{"best_route_status":"INCOMPLETE","candidate_id":"E14Q4B2822A99BAEC09","confidence":0.98,"reason":"No repeated reset, equilibrium basin, threshold recovery, or stable convention is established.","route_assessments":[{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC09R01L01","evidence":"No resets or reforms decaying back to a pattern are described.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC09R01","route_status":"INCOMPLETE"},{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC09R02L01","evidence":"No small starting-state differences with qualitatively different long-run outcomes are reported.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC09R02L02","evidence":"No undesirable stable-state geometry or basin-transition issue is described.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC09R02","route_status":"INCOMPLETE"},{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC09R03L01","evidence":"No organization or population convention is described.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC09R03L02","evidence":"No undesirable stable-state geometry or basin-transition issue is described.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC09R03","route_status":"INCOMPLETE"},{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC09R04L01","evidence":"No asymmetric decline and recovery thresholds are reported.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC09R04L02","evidence":"No undesirable stable-state geometry or basin-transition issue is described.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC09R04","route_status":"INCOMPLETE"},{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC09R05L01","evidence":"No multiple local optima, stable cycles, regimes, or equilibria are established.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC09R05L02","evidence":"No undesirable stable-state geometry or basin-transition issue is described.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC09R05","route_status":"INCOMPLETE"},{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC09R06L01","evidence":"No desired state with an inaccessible or too-small basin is described.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC09R06L02","evidence":"No undesirable stable-state geometry or basin-transition issue is described.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC09R06","route_status":"INCOMPLETE"},{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC09R07L01","evidence":"No harmful state characterized as easy to enter and hard to leave through feedback is established.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC09R07L02","evidence":"No undesirable stable-state geometry or basin-transition issue is described.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC09R07","route_status":"INCOMPLETE"}]},{"best_route_status":"SATISFIED","candidate_id":"E14Q4B2822A99BAEC10","confidence":0.99,"reason":"All required latent-state, timing, heterogeneous-response, and operating-range evidence is explicit.","route_assessments":[{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC10R01L01","evidence":"The clinically relevant drug level near the site of action is not sampled directly and is inferred imperfectly from sparse plasma measurements.","status":"SATISFIED"},{"condition_id":"E14Q4B2822A99BAEC10R01L02","evidence":"Pain relief changes twenty to forty minutes later, sedation can deepen after stopping the pump, and rescue-dose effects accumulate.","status":"SATISFIED"},{"condition_id":"E14Q4B2822A99BAEC10R01L03","evidence":"Responses differ across patients and within a patient across the shift, including with renal impairment or residual drug.","status":"SATISFIED"},{"condition_id":"E14Q4B2822A99BAEC10R01L04","evidence":"Low rates leave pain unchanged, while higher rates cause confusion, slow breathing, and prolonged recovery.","status":"SATISFIED"}],"route_id":"E14Q4B2822A99BAEC10R01","route_status":"SATISFIED"}]},{"best_route_status":"INCOMPLETE","candidate_id":"E14Q4B2822A99BAEC11","confidence":0.96,"reason":"Monitoring is described, but evidence that observation itself couples to and changes the target is absent.","route_assessments":[{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC11R01L01","evidence":"Pump delivery, scores, alertness, and blood samples are recorded, but coupling of observation to the target is not stated.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC11R01L02","evidence":"No change in target trajectory from observation intensity, timing, visibility, or repetition is described.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC11R01","route_status":"INCOMPLETE"},{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC11R02L01","evidence":"Pump delivery, scores, alertness, and blood samples are recorded, but coupling of observation to the target is not stated.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC11R02L02","evidence":"No scarce target capacity, energy, bandwidth, attention, or material consumed by data collection is stated.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC11R02","route_status":"INCOMPLETE"},{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC11R03L01","evidence":"Pump delivery, scores, alertness, and blood samples are recorded, but coupling of observation to the target is not stated.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC11R03L02","evidence":"No subject adaptation to monitoring presence is described.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC11R03","route_status":"INCOMPLETE"},{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC11R04L01","evidence":"Pump delivery, scores, alertness, and blood samples are recorded, but coupling of observation to the target is not stated.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC11R04L02","evidence":"No measurement changes caused by observation mode, dose, or sequence are reported.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC11R04","route_status":"INCOMPLETE"}]},{"best_route_status":"INCOMPLETE","candidate_id":"E14Q4B2822A99BAEC12","confidence":0.98,"reason":"The delays concern drug dynamics, not a signal degrading with distance or delayed delivery to receivers.","route_assessments":[{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC12R01L01","evidence":"No decision is described as depending on a signal remaining usable after delay or distance.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC12R01L02","evidence":"No weak-region or later receiver group losing intended signal effect is described.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC12R01L03","evidence":"No differently decaying signal components or receiver groups are reported.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC12R01L04","evidence":"No source-versus-endpoint measurement pattern is described.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC12R01","route_status":"INCOMPLETE"}]},{"best_route_status":"INCOMPLETE","candidate_id":"E14Q4B2822A99BAEC13","confidence":0.99,"reason":"The scenario is clinical pump management and provides no endpoint-completer or follow-up-loss evidence.","route_assessments":[{"condition_assessments":[{"condition_id":"E14Q4B2822A99BAEC13R01L01","evidence":"No completer-only or reachable-unit endpoint outcome frame is described.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC13R01L02","evidence":"No dropout rates, planned assumptions, or comparison groups are reported.","status":"UNKNOWN"},{"condition_id":"E14Q4B2822A99BAEC13R01L03","evidence":"No outcome- or exposure-dependent loss to follow-up is described.","status":"UNKNOWN"}],"route_id":"E14Q4B2822A99BAEC13R01","route_status":"INCOMPLETE"}]}],"opaque_case_id":"E14Q4B2822A99BAE"}